Ypsomed and ten23 health collaborate for the commercialization of the YpsoDose patch injector

News – Ypsomed Delivery Systems

Burgdorf – Ypsomed enters a partnership with ten23 health, a global Swiss contract development and manufacturing organization. The aim of this collaboration is to advance the commercialization of the YpsoDose wearable injector for the subcutaneous self-injection of large-volume doses. ten23’s drug development, filling and device assembly expertise will significantly contribute to the product offering.

Read more...

Ypsomed enhances self-injection device platforms with integrated human factors services
Ypsomed enhances self-injection device platforms with integrated human factors services

Ypsomed enhances self-injection device platforms with integrated human factors services

News – Ypsomed Delivery Systems

Burgdorf – Ypsomed announces new Human Factors (HF) services for its pharmaceutical partners to reinforce its position as a leading developer and manufacturer of self-injection solutions. By enhancing its device platform offering with integrated end-to-end HF services, Ypsomed is championing a comprehensive service approach to combination product development that de-risks regulatory approval and expedites time-to-market for its partners. To do so, Ypsomed has entered into a strategic partnership with Interface Analysis Associates LLC (IAA), a leading HF service provider with long-standing expertise in supporting the pharmaceutical industry along the full combination product development journey.

Read more...

Ypsomed partners with S3 Connected Health to expand its digital health offering

News – Ypsomed Delivery Systems

Burgdorf – Ypsomed (SIX: YPSN) will expand its offering of digital health solutions together with S3 Connected Health in the future. S3 Connected Health, headquartered in Dublin, Ireland is a specialist digital health partner for life science companies.

Topics:
Digital Health

Read more...

Ypsomed expands production facility in Schwerin

News – Ypsomed Delivery Systems

Burgdorf – Ypsomed (SIX: YPSN) is building a new production hall in Schwerin and creating 60 new jobs in the process. The company held the groundbreaking ceremony last Friday thus signaling the start of the construction for the 3300 square meters of additional production space, plus a further 1600 square meters for warehouse capacity and logistics. Digging work is scheduled to begin in June. The plant is expected to be operational following a construction phase of one year. The expansion will allow Ypsomed's site in Schwerin to produce more than 250 million infusion sets, pens and autoinjectors per year going forward.

Read more...

Digital therapy management from Ypsomed for self-treatment

News – Ypsomed Delivery Systems

A message appears on Anna's smartphone; it's time for her next injection. The 19-year-old suffers from psoriasis and has to inject herself regularly with a medication. Anna is a little nervous, because the needle, the prick and the slight pain still make her feel uncomfortable. With the support of the app on her smartphone and her YpsoMate auto-injector, combined with the SmartPilot, she gets over herself, administers the injection that is due and is delighted when a treasure chest opens on the screen and golden light pours out. It shows her that she has done everything right.

Read more...